COVID-19 Vaccine Acceptance and Associated Factors among Women in Saudi Arabia: A Cross-Sectional Study
Abstract
1. Introduction
2. Materials and Methods
Variables
3. Results
4. Discussion
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Chang, W.-H. A review of vaccine effects on women in light of the COVID-19 pandemic. Taiwan. J. Obstet. Gynecol. 2020, 59, 812–820. [Google Scholar] [CrossRef] [PubMed]
- Zheng, Z.; Diaz-Arévalo, D.; Guan, H.; Zeng, M. Noninvasive vaccination against infectious diseases. Hum. Vaccines Immunother. 2018, 14, 1717–1733. [Google Scholar] [CrossRef] [PubMed]
- WHO. WHO Issues Its First Emergency Use Validation for a COVID-19 Vaccine and Emphasizes Need for Equitable Global Access. Available online: https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access (accessed on 23 July 2022).
- Murewanhema, G. Vaccination hesitancy among women of reproductive age in resource-challenged settings: A cause for public health concern. Pan Afr. Med. J. 2021, 38, 336. [Google Scholar] [CrossRef] [PubMed]
- Nachega, J.B.; Sam-Agudu, N.A.; Masekela, R.; van der Zalm, M.M.; Nsanzimana, S.; Condo, J.; Ntoumi, F.; Rabie, H.; Kruger, M.; Wiysonge, C.S.; et al. Addressing challenges to rolling out COVID-19 vaccines in African countries. Lancet Glob. Health 2021, 9, e746–e748. [Google Scholar] [CrossRef]
- Dzinamarira, T.; Nachipo, B.; Phiri, B.; Musuka, G. COVID-19 vaccine roll-out in South Africa and Zimbabwe: Urgent need to address community preparedness, fears and hesitancy. Vaccines 2021, 9, 250. [Google Scholar] [CrossRef]
- Paul, E.; Steptoe, A.; Fancourt, D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg. Health Eur. 2021, 1, 100012. [Google Scholar] [CrossRef]
- Sallam, M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef]
- Alfageeh, E.I.; Alshareef, N.; Angawi, K.; Alhazmi, F.; Chirwa, G.C. Acceptability of a COVID-19 vaccine among the Saudi population. Vaccines 2021, 9, 226. [Google Scholar] [CrossRef]
- Larson, H.J.; Gakidou, E.; Murray, C.J.L. The vaccine-hesitant moment. N. Engl. J. Med. 2022, 387, 58–65. [Google Scholar] [CrossRef]
- Wenham, C.; Smith, J.; Morgan, R. Gender and COVID-19 working group COVID-19: The gendered impacts of the outbreak. Lancet 2020, 395, 846–848. [Google Scholar] [CrossRef]
- Peckham, H.; de Gruijter, N.M.; Raine, C.; Radziszewska, A.; Ciurtin, C.; Wedderburn, L.R.; Rosser, E.C.; Webb, K.; Deakin, C.T. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat. Commun. 2020, 11, 6317. [Google Scholar] [CrossRef] [PubMed]
- United Nations. UN Secretary-General’s Policy Brief: The Impact of COVID-19 on Women. Available online: https://www.unwomen.org/en/digital-library/publications/2020/04/policy-brief-the-impact-of-covid-19-on-women (accessed on 23 July 2022).
- Nkangu, M.N.; Olatunde, O.A.; Yaya, S. The perspective of gender on the Ebola virus using a risk management and population health framework: A scoping review. Infect. Dis. Poverty 2017, 6, 135. [Google Scholar] [CrossRef] [PubMed]
- Menéndez, C.; Lucas, A.; Munguambe, K.; Langer, A. Ebola crisis: The unequal impact on women and children’s health. Lancet Glob. Health 2015, 3, e130. [Google Scholar] [CrossRef]
- AFDB. Women’s Resilience: Integrating Gender in the Response to Ebola—GSDRC. Available online: https://gsdrc.org/document-library/womens-resilience-integrating-gender-in-the-response-to-ebola/ (accessed on 23 July 2022).
- OECD. Women at the Core of the Fight against COVID-19 Crisis. Available online: https://www.oecd.org/coronavirus/policy-responses/women-at-the-core-of-the-fight-against-covid-19-crisis-553a8269/ (accessed on 23 July 2022).
- Qattan, A.M.N. Symptoms of psychological distress amongst women during the COVID-19 pandemic in Saudi Arabia. PLoS ONE 2022, 17, e0268642. [Google Scholar] [CrossRef] [PubMed]
- Liu, N.; Zhang, F.; Wei, C.; Jia, Y.; Shang, Z.; Sun, L.; Wu, L.; Sun, Z.; Zhou, Y.; Wang, Y.; et al. Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: Gender differences matter. Psychiatry Res. 2020, 287, 112921. [Google Scholar] [CrossRef]
- Machida, M.; Nakamura, I.; Kojima, T.; Saito, R.; Nakaya, T.; Hanibuchi, T.; Takamiya, T.; Odagiri, Y.; Fukushima, N.; Kikuchi, H.; et al. Acceptance of a COVID-19 vaccine in Japan during the COVID-19 pandemic. Vaccines 2021, 9, 210. [Google Scholar] [CrossRef]
- Qattan, A.M.N.; Alshareef, N.; Alsharqi, O.; Al Rahahleh, N.; Chirwa, G.C.; Al-Hanawi, M.K. Acceptability of a COVID-19 vaccine among healthcare workers in the Kingdom of Saudi Arabia. Front. Med. 2021, 8, 644300. [Google Scholar] [CrossRef]
- Al-Hanawi, M.K.; Alshareef, N.; El-Sokkary, R.H. Willingness to receive COVID-19 vaccination among older adults in Saudi Arabia: A community-based survey. Vaccines 2021, 9, 1257. [Google Scholar] [CrossRef]
- Sherman, S.M.; Smith, L.E.; Sim, J.; Amlôt, R.; Cutts, M.; Dasch, H.; Rubin, G.J.; Sevdalis, N. COVID-19 vaccination intention in the UK: Results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum. Vaccines Immunother. 2020, 17, 1612–1621. [Google Scholar] [CrossRef]
- Kabamba Nzaji, M.; Kabamba Ngombe, L.; Ngoie Mwamba, G.; Banza Ndala, D.B.; Mbidi Miema, J.; Lungoyo, C.L.; Mwimba, B.L.; Bene, A.C.M.; Musenga, E.M. Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of the Congo. Pragmatic Obs. Res. 2020, 11, 103–109. [Google Scholar] [CrossRef]
- Harapan, H.; Wagner, A.L.; Yufika, A.; Winardi, W.; Anwar, S.; Gan, A.K.; Setiawan, A.M.; Rajamoorthy, Y.; Sofyan, H.; Mudatsir, M. Acceptance of a COVID-19 vaccine in Southeast Asia: A cross-sectional study in Indonesia. Front. Public Health 2020, 8, 381. [Google Scholar] [CrossRef] [PubMed]
- Quinn, S.C.; Jamison, A.M.; An, J.; Hancock, G.R.; Freimuth, V.S. Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: Results of a national survey of white and African American adults. Vaccine 2019, 37, 1168–1173. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Jing, R.; Lai, X.; Zhang, H.; Lyu, Y.; Knoll, M.D.; Fang, H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines 2020, 8, 482. [Google Scholar] [CrossRef]
- Lazarus, J.V.; Wyka, K.; Rauh, L.; Rabin, K.; Ratzan, S.; Gostin, L.O.; Larson, H.J.; El-Mohandes, A. Hesitant or not? The association of age, gender, and education with potential acceptance of a COVID-19 vaccine: A country-level analysis. J. Health Commun. 2020, 25, 799–807. [Google Scholar] [CrossRef] [PubMed]
- Samannodi, M. COVID-19 vaccine acceptability among women who are pregnant or planning for pregnancy in Saudi Arabia: A cross-sectional study. Patient Prefer. Adherence 2021, 15, 2609–2618. [Google Scholar] [CrossRef] [PubMed]
- Reno, C.; Maietti, E.; Fantini, M.P.; Savoia, E.; Manzoli, L.; Montalti, M.; Gori, D. Enhancing COVID-19 vaccines acceptance: Results from a survey on vaccine hesitancy in northern Italy. Vaccines 2021, 9, 378. [Google Scholar] [CrossRef]
- Dratva, J.; Wagner, A.; Zysset, A.; Volken, T. To vaccinate or not to vaccinate—This is the question among Swiss University students. Int. J. Environ. Res. Public. Health 2021, 18, 9210. [Google Scholar] [CrossRef]
- Lin, C.J.; Nowalk, M.P.; Toback, S.L.; Rousculp, M.D.; Raymund, M.; Ambrose, C.S.; Zimmerman, R.K. Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults. Vaccine 2010, 28, 7706–7712. [Google Scholar] [CrossRef]
- Wang, K.; Wong, E.L.Y.; Ho, K.F.; Cheung, A.W.L.; Chan, E.Y.Y.; Yeoh, E.K.; Wong, S.Y.S. Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey. Vaccine 2020, 38, 7049–7056. [Google Scholar] [CrossRef]
- Biasio, L.R. Vaccine hesitancy and health literacy. Hum. Vaccines Immunother. 2016, 13, 701–702. [Google Scholar] [CrossRef]
Variable | Not Willing to Accept COVID-19 Vaccination n = 538 59.12% | Willing to Accept COVID-19 Vaccination n = 372 40.88% | Total (%) n = 910 | p-Value | |||
---|---|---|---|---|---|---|---|
A | B | C | D | ||||
Age (years) | |||||||
18 to 29 | 134 | 24.91 | 136 | 36.56 | 270 | 29.67 | <0.001 *** |
30 to 39 | 187 | 34.76 | 105 | 28.23 | 292 | 32.09 | |
40 to 49 | 98 | 18.22 | 65 | 17.47 | 163 | 17.91 | |
50 to 59 | 74 | 13.75 | 43 | 11.56 | 117 | 12.86 | |
≥60 | 45 | 8.36 | 23 | 6.18 | 68 | 7.47 | |
Marital status | |||||||
Unmarried | 184 | 34.20 | 172 | 46.24 | 356 | 39.12 | <0.001 *** |
Married | 354 | 65.80 | 200 | 53.76 | 554 | 60.88 | |
Educational level | |||||||
High school or below | 101 | 18.77 | 120 | 32.26 | 221 | 24.29 | <0.001 *** |
Bachelor’s degree | 271 | 50.37 | 185 | 49.73 | 456 | 50.11 | |
Postgraduate degree | 166 | 30.86 | 67 | 18.01 | 233 | 25.60 | |
Employment status | |||||||
Government employee | 194 | 36.06 | 110 | 29.57 | 304 | 33.41 | <0.001 *** |
Private sector employee | 44 | 8.18 | 26 | 6.99 | 70 | 7.69 | |
Self-employed | 20 | 3.72 | 9 | 2.42 | 29 | 3.19 | |
Student | 53 | 9.85 | 94 | 25.27 | 147 | 16.15 | |
Retired | 57 | 10.59 | 22 | 5.91 | 79 | 8.68 | |
Unemployed | 170 | 31.60 | 111 | 29.84 | 281 | 30.88 | |
Suffer from chronic disease | |||||||
No | 418 | 77.70 | 286 | 76.88 | 704 | 77.36 | 0.773 |
Yes | 120 | 22.30 | 86 | 23.12 | 206 | 22.64 | |
Received flu vaccine in past | |||||||
No | 306 | 56.88 | 156 | 41.94 | 462 | 50.77 | <0.001 *** |
Yes | 232 | 43.12 | 216 | 58.06 | 448 | 49.23 | |
Refused vaccination in past | |||||||
No | 324 | 60.22 | 341 | 91.67 | 665 | 73.08 | <0.001 *** |
Yes | 214 | 39.78 | 31 | 8.33 | 245 | 26.92 | |
Family member(s) infected with COVID-19 | |||||||
No | 304 | 56.51 | 223 | 59.95 | 527 | 57.91 | 0.301 |
Yes | 234 | 43.49 | 149 | 40.05 | 383 | 42.09 | |
Friend(s) infected with COVID-19 | |||||||
No | 78 | 14.50 | 45 | 12.10 | 123 | 13.52 | 0.298 |
Yes | 460 | 85.50 | 327 | 87.90 | 787 | 86.48 | |
Lost family member or friend due to complications from COVID-19 | |||||||
No | 410 | 76.21 | 262 | 70.43 | 672 | 73.85 | 0.051 * |
Yes | 128 | 23.79 | 110 | 29.57 | 238 | 26.15 | |
Perceived risk of COVID-19 | |||||||
Minor or no risk | 144 | 26.77 | 47 | 12.63 | 191 | 20.99 | <0.001 *** |
Moderate risk | 203 | 37.73 | 117 | 31.45 | 320 | 35.16 | |
Significant or major risk | 191 | 35.50 | 208 | 55.91 | 399 | 43.85 | |
Concerned about becoming infected with COVID-19 | |||||||
Low or very low | 271 | 50.37 | 104 | 27.96 | 375 | 41.21 | <0.001 *** |
Fair | 153 | 28.44 | 134 | 36.02 | 287 | 31.54 | |
High or very high | 114 | 21.19 | 134 | 36.02 | 248 | 27.25 | |
COVID-19 vaccine should be compulsory for all citizens and residents | |||||||
No | 521 | 96.84 | 115 | 30.91 | 636 | 69.89 | <0.001 *** |
Yes | 17 | 3.16 | 257 | 69.09 | 274 | 30.11 |
Variable | OR | 95% CI | p-Value |
---|---|---|---|
Age (years) | |||
18 to 29 (ref) | |||
30 to 39 | 1.259 | 0.625–2.534 | 0.519 |
40 to 49 | 2.209 | 1.019–4.789 | 0.045 ** |
50 to 59 | 1.474 | 0.611–3.559 | 0.388 |
≥60 | 2.129 | 0.752–6.027 | 0.155 |
Marital status | |||
Unmarried (ref) | |||
Married | 0.817 | 0.500–1.336 | 0.421 |
Educational level | |||
High school or below (ref) | |||
Bachelor’s degree | 0.654 | 0.392–1.093 | 0.105 |
Postgraduate degree | 0.431 | 0.220–0.847 | 0.015 ** |
Employment status | |||
Government employee (ref) | |||
Private sector employee | 0.885 | 0.375–2.088 | 0.780 |
Self-employed | 0.887 | 0.224–3.506 | 0.864 |
Student | 2.285 | 0.990–5.274 | 0.053 * |
Retired | 0.548 | 0.206–1.453 | 0.226 |
Unemployed | 1.056 | 0.582–1.916 | 0.858 |
Suffer from chronic disease | |||
No (ref) | |||
Yes | 0.838 | 0.501–1.403 | 0.502 |
Received flu vaccine in past | |||
No (ref) | |||
Yes | 1.016 | 0.671–1.538 | 0.942 |
Refused vaccination in past | |||
No (ref) | |||
Yes | 0.152 | 0.083–0.275 | <0.001 *** |
Family member(s) infected with COVID-19 | |||
No (ref) | |||
Yes | 1.318 | 0.852–2.040 | 0.215 |
Friend(s) infected with COVID-19 | |||
No (ref) | |||
Yes | 1.110 | 0.478–1.665 | 0.719 |
Lost family member or friend due to complications from COVID-19 | |||
No (ref) | |||
Yes | 1.167 | 0.723–1.883 | 0.527 |
Perceived risk of COVID-19 | |||
Minor or no risk (ref) | |||
Moderate risk | 1.047 | 0.566–1.939 | 0.883 |
Significant or major risk | 1.266 | 0.679–2.363 | 0.458 |
Concerned about becoming infected with COVID-19 | |||
Low or very low (ref) | |||
Fair | 2.570 | 1.562–4.228 | <0.001 *** |
High or very high | 1.925 | 1.093–3.390 | 0.023 ** |
COVID-19 vaccine should be compulsory for all citizens and residents | |||
No (ref) | |||
Yes | 64.916 | 35.911–117.351 | <0.001 *** |
Reason | N | % |
---|---|---|
Fear of adverse side effects | 160 | 29.74 |
Safety and efficacy concerns | 113 | 21.00 |
The speed of making the vaccine | 23 | 4.28 |
The short duration of clinical trials | 73 | 13.57 |
Personal preference to not get vaccinated | 46 | 8.55 |
Belief that the vaccine is a plot | 40 | 7.43 |
Belief that the virus does not exist | 7 | 1.30 |
Belief that masks and sanitizers are sufficient for protection | 32 | 5.95 |
Other | 44 | 8.18 |
Total | 538 | 100 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alshareef, N. COVID-19 Vaccine Acceptance and Associated Factors among Women in Saudi Arabia: A Cross-Sectional Study. Vaccines 2022, 10, 1842. https://doi.org/10.3390/vaccines10111842
Alshareef N. COVID-19 Vaccine Acceptance and Associated Factors among Women in Saudi Arabia: A Cross-Sectional Study. Vaccines. 2022; 10(11):1842. https://doi.org/10.3390/vaccines10111842
Chicago/Turabian StyleAlshareef, Noor. 2022. "COVID-19 Vaccine Acceptance and Associated Factors among Women in Saudi Arabia: A Cross-Sectional Study" Vaccines 10, no. 11: 1842. https://doi.org/10.3390/vaccines10111842
APA StyleAlshareef, N. (2022). COVID-19 Vaccine Acceptance and Associated Factors among Women in Saudi Arabia: A Cross-Sectional Study. Vaccines, 10(11), 1842. https://doi.org/10.3390/vaccines10111842